Evidence map›Paper›PMID 32650623›Full record

ArticleBiology2020

Assessment of Cytocompatibility and Anti-Inflammatory (Inter)Actions of Genipin-Crosslinked Chitosan Powders.

Simona Dimida, Matteo Santin, Tiziano Verri, Amilcare Barca, Christian Demitri

Open access · goldAbstract read
In one paragraph

Article in Biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Development andBioMed research international · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Simona DimidaBiomaterial Laboratory, Department of Innovation for Engineering, University of Salento c/o Ecotekne, 73100 Lecce, Italy.ORCID 0000-0003-2026-1745
Matteo SantinCentre for Regenerative Medicine and Devices, School of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton BN24GJ, United Kingdom.ORCID 0000-0002-5260-7088
Tiziano VerriApplied Physiology Laboratory, Department of Biological and Environmental Sciences and Technologies, University of Salento c/o Ecotekne, 73100 Lecce, Italy.
Amilcare BarcaApplied Physiology Laboratory, Department of Biological and Environmental Sciences and Technologies, University of Salento c/o Ecotekne, 73100 Lecce, Italy.ORCID 0000-0002-3117-2724
Christian DemitriBiomaterial Laboratory, Department of Innovation for Engineering, University of Salento c/o Ecotekne, 73100 Lecce, Italy.
University of Salento · ITUniversity of Brighton · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chitosan is a polysaccharide commonly used, together with its derivatives, in the preparation of hydrogel formulations, scaffolds and films for tissue engineering applications. Chitosan can be used as such, but it is commonly stabilized by means of chemical crosslinkers. Genipin is one of the crosslinkers that has been considered that is a crystalline powder extracted from the fruit of

Indexed as

biomaterialscell–material interactionschitosangenipininflammation

Identifiers

PMID32650623
PMCPMC7407416
OpenAlexW3041363635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.